Mental Health Clinics in Milpitas, CA Accepting Medicare
14 Mental Health Clinics found. Showing 1 - 14
 Cassy Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 544 Valley Way, Milpitas, CA 95035 Phone: 408-493-5289 |
Aars, Youth Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 542 Valley Way, Milpitas, CA 95035 Phone: 408-934-1110 Fax: 408-271-3909 |
Department Of Alcohol And Drug Services-cfcs-milpitas High Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1285 Escuela Pkwy, Milpitas, CA 95035 Phone: 408-945-5500 |
Liliana L Ramos Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1525 Mccarthy Blvd Ste 1097, Milpitas, CA 95035 Phone: 408-219-6676 |
Ohana Therapies Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 723 Jennifer Way, Milpitas, CA 95035 Phone: 484-985-0189 |
Ohana Behavioral Connection Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 723 Jennifer Way, Milpitas, CA 95035 Phone: 484-985-0189 |
Silicon Valley Aba And Consulting Services Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1613 S Main St Ste 103, Milpitas, CA 95035 Phone: 408-476-3208 |
M.a. Katz Psychological Services, Inc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 830 Hillview Ct Ste 260, Milpitas, CA 95035 Phone: 925-989-5643 |
We Strive Aba Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1828 S Milpitas Blvd Apt 538, Milpitas, CA 95035 Phone: 209-485-3715 |
Department Of Alcohol And Drug Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1331 E Calaveras Blvd, Milpitas, CA 95035 Phone: 408-719-5063 |
Social Play And More Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 531 S Main St, Milpitas, CA 95035 Phone: 408-824-5099 |
County Of Santa Clara Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 143 N Main St, Milpitas, CA 95035 Phone: 408-885-1234 |
Department Of Alcohol And Drug Services-cfcs-calaveras Hills Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1331 E Calaveras Blvd, Milpitas, CA 95035 Phone: 408-945-2398 |
Milpitas High School Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1285 Escuela Drive, Milpitas, CA 95035 Phone: 408-271-3900 Fax: 408-271-3909 |
News Archive
Nationwide Swedish study strengthens evidence for a third booster COVID vaccine dose
A nationwide study from Sweden investigates the effectiveness of COVID-19 vaccination against the risk of symptomatic infection, hospitalization, and death up to 9 months post-vaccination. This study is published on the Preprints with The Lancet website while awaiting peer review.
China admits to the extent of pig disease
China has, for the first time admitted to the number of pigs which have been killed by a deadly bacteria. The bacteria, Streptococcus suis, or Swine flu, has also claimed the lives of at least 38 people, and made over a hundred sick, who slaughtered, handled or ate the infected animals.
Saskatchewan government makes insulin detemir more accessible to residents
The Canadian Diabetes Association applauds the Government of Saskatchewan for increasing access to insulin detemir for residents of Saskatchewan living with diabetes. Insulin detemir, also known as Levemir, has been added to the Saskatchewan Drug Formulary, under Exception Drug Status (EDS) effective July 1, 2009. As well, the updated formulary now includes NovoRapid-NOO, Apidra-AVT and Humalog-LIL within its Revised Exception Drug Status Criteria.
GRAVITAS study shows no benefit of double-dose compared with standard-dose clopidogrel
An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high on-treatment platelet reactivity does not reduce the incidence on death, heart attacks and stent thrombosis after percutaneous coronary intervention.
› Verified 4 days ago